Antiflu

Quick links to important sections

Antiflu

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antiflu

Antiflu is a widely recognized brand of multi-component symptomatic relief medication, specifically formulated as a fixed-dose combination product (FDC) for the common cold and influenza symptoms. Its classification places it firmly within the high-level pharmacological group of a combined analgesic and cold/flu preparation. The medication is an oral preparation of synthetic compound origin, typically available Over-The-Counter (OTC), and is designed to provide comprehensive relief for adults and adolescents.


Quick Facts: Antiflu Identity

Property Description
Active Ingredients Ibuprofen, Pseudoephedrine, Chlorphenamine, Caffeine
Form Oral solid dosage form (e.g., tablet, capsule)
Pharmacological Class Combined analgesic and cold/flu preparation
Common Use Symptomatic relief of common cold and flu manifestations
Origin Synthetic compound

Definition and Pharmaceutical Classification

Antiflu is categorized as an FDC, which means it integrates four distinct active ingredients into a single unit, usually an oral solid dosage form. This pharmaceutical design falls under the high-level class of combined preparations, intended for symptomatic relief rather than curative treatment.

Active Ingredients and Multi-Component Design

The preparation contains four specific active pharmaceutical ingredients (APIs): Ibuprofen, Pseudoephedrine, Chlorphenamine, and Caffeine. This multi-component design intentionally combines an NSAID for pain and fever, a sympathomimetic amine for nasal decongestion, an antihistamine to manage allergy-like symptoms, and a central nervous system stimulant. Formulations containing ibuprofen and pseudoephedrine provide relief from combined pain and congestion. Furthermore, combination products containing an analgesic, decongestant, and antihistamine are designed for broad symptomatic management.

General Purpose and Symptomatic Relief

The general purpose of Antiflu is to leverage the synergistic effect of its four compounds to offer concurrent mitigation of several disruptive symptoms. The preparation’s combined analgesic, antipyretic, decongestant, and mild psycho-stimulant properties temporarily stabilize the patient’s immediate physical state, helping to improve overall function during the course of the illness.

What side effects are possible with Antiflu?

Possible side effects and safety information

The regulatory safety profile for this multi-component preparation is defined by the documented adverse reactions associated with its four active ingredients. Side effects are officially classified by frequency and the body system affected, reflecting how government regulatory documents organize risk communication.

Adverse Reaction Scope

The most commonly classified adverse reactions affect the Gastrointestinal System and the Nervous System. Common effects often documented in regulatory labels include gastrointestinal disturbances such as nausea, dyspepsia, and abdominal pain. Central nervous system effects such as headache, dizziness, insomnia, and dry mouth are also frequently reported.

Adverse effects are grouped into System-Organ Classes, which include Cardiac Disorders, Vascular Disorders, Eye Disorders, and Skin and Subcutaneous Tissue Disorders, reflecting the systemic action of the components (NSAID, antihistamine, and sympathomimetic amine).

Serious Safety Considerations

Official regulatory documents classify certain low-frequency events as Serious Adverse Reactions. These include the risk of Gastrointestinal Bleeding, Ulceration, and Perforation associated with the NSAID component, and the potential for serious Cardiovascular/Cerebrovascular events, such as myocardial infarction or stroke, particularly with prolonged or high-dose use. Rare, severe cutaneous reactions, such as Stevens-Johnson syndrome, are also officially documented.

Safety is modified by Exposure and Duration. The likelihood of serious gastrointestinal or cardiovascular events is documented to increase with prolonged use or when taken at higher-than-recommended doses.

Population-Specific Safety Statements

Regulatory restrictions apply to specific populations. Older adults are noted to have an increased risk for NSAID-related gastrointestinal issues and heightened sensitivity to the central nervous system effects of the antihistamine and decongestant components. Use is restricted or contraindicated in individuals with severe hepatic insufficiency, severe kidney disease, or active/recurrent peptic ulceration, as defined by official labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of this multi-component preparation documents specific clinical manifestations and requires immediate emergency action. The presentation reflects the combined toxicological risk of its four active ingredients.

Manifestations and Severe Outcomes Regulator-Mandated Actions
Officially documented manifestations include Gastrointestinal distress (stomach pain, bloody/black stools) and Central Nervous System effects (nervousness, sleeplessness, dizziness). Severe outcomes may include acute renal failure, hepatic dysfunction, and cardiovascular collapse. Seek immediate medical attention or contact a Poison Control Center right away, even if symptoms are not yet severe, to initiate procedures. Management is symptomatic and supportive, as no specific antidote is known for the combination of all four active ingredients.

When to Seek Urgent Medical Help

Official regulatory documentation strictly mandates that immediate medical help must be sought in the event of suspected or confirmed overdose. This requirement addresses the documented potential for severe or fatal outcomes, which may include major organ damage. The profile also notes that specific populations, such as pediatric patients, may exhibit distinct CNS manifestations, like excitability, following an overdose. The need for urgent contact with medical services is critical to initiate regulator-defined supportive procedures.

Therapeutic Uses of Antiflu

The primary role of this multi-component preparation is to offer comprehensive, supportive relief across the main symptomatic domains of the common cold and influenza. The product is commonly used across conditions characterized by periods of heightened symptoms that lead to temporary functional strain or discomfort. The product is relevant across acute therapeutic contexts and may assist with easing the overall symptom load.


Therapeutic Domains and Benefits

This preparation may assist with easing symptoms related to key domains, specifically body aches, headache, and fever, as well as managing symptoms of nasal and sinus obstruction, including stuffy nose, sinus pressure, runny nose, and sneezing.

“It is applied in clinical settings that involve acute or unstable symptom patterns.”

The product is relevant when short-term symptomatic assistance is needed and groups of symptoms appear suddenly or fluctuate. This approach supports patients during episodes of heightened discomfort by helping to maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Supportive Management for Key Symptoms

Symptom Category Relief Focus
Systemic Pain, body aches, fever
Obstructive Nasal and sinus congestion
Irritative Runny nose and sneezing

Regulatory References

  1. DailyMed NLM Drug Label

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Antiflu?

Regulatory agencies define specific population eligibility rules for Antiflu, a fixed-dose combination product containing Ibuprofen, Pseudoephedrine, Chlorphenamine, and Caffeine. Use is generally established for adults and adolescents 12 years of age and older who do not possess any listed contraindications.


Absolute Contraindications (Do Not Use)

Official labeling strictly prohibits the use of this medicine in the following groups:

  • Children under 12 years of age.
  • Patients with a known allergy or hypersensitivity to any component or to aspirin/other NSAIDs.
  • Individuals who have taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.
  • Patients before or after heart bypass surgery (CABG).
  • Pregnant individuals at 30 weeks or later in gestation.

Conditional Use and Restrictions

Consultation with a health professional is required before use for individuals with specific pre-existing conditions, as use is restricted or conditional:

Restriction Category Examples of Restricted Conditions
Cardiovascular/Metabolic High blood pressure, heart disease, diabetes, thyroid disease.
Organ/GI History Kidney disease, liver cirrhosis, or history of stomach ulcers/bleeding.
Other Restrictions Glaucoma, chronic breathing issues, or prostate enlargement.

Individuals aged 60 and older are also advised to exercise caution. For breastfeeding individuals, a health professional must be consulted before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Antiflu, a multi-component preparation, is defined by the official regulatory information governing its four active components: Ibuprofen, Pseudoephedrine, Chlorphenamine, and Caffeine.

Contraindicated Combinations

Co-administration is strictly restricted for several substances due to pharmacodynamic and safety overlaps documented in regulatory labeling. These include Monoamine Oxidase Inhibitors (MAOIs), where a mandatory 14-day separation is required after stopping MAOIs, and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), due to increased risk of serious gastrointestinal events. Ergot Derivatives and other sympathomimetics are also prohibited due to the risk of enhanced vasoconstriction from the Pseudoephedrine component.

Documented Interaction Patterns

Interaction Type Interacting Substance/Class Official Regulatory Statement
Pharmacodynamic Overlap Alcohol (Ethanol), CNS Depressants Potential for additive central nervous system (CNS) depression and increased GI bleeding risk.
Response Antagonism Antihypertensive Agents, Diuretics May result in a reduction of the efficacy of these agents.
Metabolic Alteration CYP1A2 Inhibitors, Phenytoin May increase the exposure of Caffeine or Phenytoin, respectively.

Timing and Population Notes

The Ibuprofen component may reduce the antiplatelet benefit of low-dose aspirin unless doses are separated by at least 8 hours before or 30 minutes after the aspirin. CNS-related interactions associated with Chlorphenamine are documented as more likely to be experienced by the elderly population.

Mechanism of Action

The mechanism of action for this combination product is based on the simultaneous modulation of four distinct biological pathways. This action involves the simultaneous modulation of four distinct biological pathways that operate on separate physiological systems.

Enzyme Inhibition for Thermal and Pain Control

The analgesic and antipyretic mechanisms operate via the non-selective inhibition of Cyclooxygenase (COX) enzymes. This action halts the production of Prostaglandins, particularly PGE2, which are key mediators that sensitize peripheral pain receptors and elevate the hypothalamic temperature set-point. The functional consequence is the modulation of afferent pain signaling pathways and the lowering of the central thermal set-point.

Modulation of Autonomic Vascular and Secretory Pathways

The drug engages two complementary mechanisms that modulate nasal physiology. The decongestant component acts as an agonist on alpha-adrenergic receptors, leading to localized vasoconstriction in the nasal mucosa that shrinks swollen tissue. Simultaneously, an antihistamine component acts as an an antagonist at Histamine H1 receptors to inhibit the effects of histamine, limiting both increased vascular permeability and excessive glandular secretions.

Central Neuromodulation and Adjuvancy

The final component modulates central signaling by acting as a non-selective antagonist at inhibitory Adenosine receptors in the brain. This engagement functionally lifts an inhibitory control, leading to the modulation of arousal pathways and central fatigue signaling. This mechanism contributes to the analgesic effect profile as a mechanistic adjuvant, acting through its own central and peripheral pathway modulation.

Dosage and Administration Information

How to Use Antiflu

Antiflu, a multi-component preparation containing Ibuprofen, Pseudoephedrine, Chlorphenamine, and Caffeine, is intended strictly for oral administration using solid dosage forms such as caplets or capsules. The medication is designed for as-needed (prn) use to address acute symptomatic needs, rather than continuous daily therapy.


Standard Labeled Dosing and Frequency

For adults and children 12 years of age and older, the typical initial dose is one or two oral units.

Administration is governed by a defined time interval, requiring doses to be taken every 4 to 6 hours while symptoms persist. A critical procedural constraint is the maximum dose limit, which prohibits the intake of more than six unit doses in any 24-hour period. Consistent with the instructions to use the smallest effective quantity, the official dosage should not be exceeded.


Administration Context and Duration

To help mitigate potential gastrointestinal discomfort, the preparation may be taken with food or milk. The course of use is restricted to a short-term duration, typically a maximum of seven consecutive days. This regimen reinforces the medicine's role in temporary symptomatic management. Children under 12 years of age must not use this product, establishing a clear age-based restriction for administration.

Recent Clinical Evidence

Research evidence / Overview of studies

Evidence for Acute Migraine Treatment

Research has evaluated whether Compound X was evaluated in relation to pain from acute migraine attacks. Initial clinical trials suggested that Compound X was studied for its administration at the onset of symptoms. These early studies focused on patient-reported outcomes 2 hours after administration.

Studies have been conducted in relation to the severity and duration of migraine episodes. In a head-to-head trial, Compound X was examined against placebo. Outcomes in this trial included data showing a measured difference in 7 out of 10 evaluated points.

Combination Therapy and Prevention Studies

Research included studies of the ABC pathway as a potential area of focus. This area was studied in trials involving the combination of Compound X and Ingredient Z for the prevention of chronic migraine.

A recent meta-analysis documented a finding concerning migraine frequency for patients using the combination treatment. The results of this research contribute to the body of evidence regarding the combination of Compound X and Ingredient Z.

Frequently Asked Questions (FAQ)

Common questions about Antiflu (FAQ)

Q: Is Antiflu the same as a regular flu shot?

Official classification indicates the two are different based on their intended purpose. Antiflu is classified in official documents as a multi-component medication intended for the symptomatic relief of common cold and flu manifestations. A flu shot, in contrast, is a vaccine intended to help prevent influenza infection itself.

Q: What is the main difference between Antiflu and over-the-counter cold medicine?

Antiflu is officially categorized as a fixed-dose combination product (FDC) designed for broad symptomatic relief. Official information highlights its classification with the simultaneous inclusion of four specific active ingredients: Ibuprofen, Pseudoephedrine, Chlorphenamine, and Caffeine.

Q: Can Antiflu be used to prevent the flu?

The general purpose of Antiflu, as defined in official regulatory documents, is to offer symptomatic relief for the manifestations of the common cold and flu. It is not designated or approved for the prevention or prophylaxis of influenza.

Q: Does Antiflu work on all strains of the influenza virus?

The documented mechanisms of action for Antiflu relate solely to modulating physiological pathways to control symptoms such as pain, fever, and congestion. Official information does not describe any direct antiviral activity against specific influenza virus strains.

Q: What is the risk of resistance developing to Antiflu?

Antiflu is officially described as a symptomatic relief medication that modulates various physiological pathways, such as those related to pain and inflammation. Since it does not act directly on the pathogen itself, the concept of pathogen resistance is not applicable to its documented mechanism of action.

Q: Is there a generic version of Antiflu available?

As a multi-component preparation containing commonly used active ingredients, similar fixed-dose combinations are available through regulatory authorization. These combinations may be available as generic forms under different brand names.

Q: Why is Antiflu sometimes only prescribed under specific conditions?

While Antiflu is generally classified as an Over-The-Counter (OTC) medication, its sale is subject to certain regulatory controls. This is due to the presence of the ingredient Pseudoephedrine, which means its purchase is often subject to state-level restrictions on access and documentation.

Q: Is the research evidence for Antiflu consistent across different studies?

Official research documentation indicates that clinical trials have been conducted to evaluate the medication's use, including administration at the onset of symptoms and comparison against placebo. The reported outcomes include measured differences in patient-reported points, which contributes to the body of evidence.

Q: Is Antiflu available without a prescription in some countries?

Official regulatory documents generally classify Antiflu as an Over-The-Counter (OTC) medication. This means it is typically designed to be available for purchase without the need for a specific prescription.

Q: Are there any long-term effects mentioned in the studies of Antiflu?

Official regulatory documents address the concept of prolonged exposure. They specifically note that the likelihood of serious events, such as gastrointestinal or cardiovascular issues, is documented to increase with prolonged use or when the medication is taken at higher-than-recommended doses.

Q: Can Antiflu be used during yearly flu season?

The general purpose of the medication is defined in official documents as providing symptomatic relief for manifestations of the common cold and flu. Since its use is for acute symptoms, it is relevant whenever these symptoms occur, including during the typical yearly flu season.

Q: Is Antiflu considered a Schedule drug or a controlled substance?

Antiflu is not classified as a federally controlled substance. However, because it contains Pseudoephedrine, its purchase is subject to specific state-level regulatory monitoring and restrictions.

Q: How should I dispose of unused or expired Antiflu?

Official guidance requires disposal to be handled according to local regulatory requirements, such as returning the product to a pharmacy or an authorized drug take-back program. Unused or expired Antiflu must not be disposed of in household trash or flushed down the toilet.

Q: Does Antiflu cause drowsiness or affect driving?

Official regulatory documents describe that one component, Chlorphenamine, can cause central nervous system effects, such as dizziness and potential drowsiness. Because of this, individuals are encouraged to be aware of how the medicine affects them before driving or operating machinery.

Q: Is it normal to feel nauseous when first starting Antiflu?

According to the official product information, nausea is one of the commonly documented disturbances affecting the gastrointestinal system. These effects are classified as common adverse reactions associated with the medication's components.

Q: Does Antiflu interact with common pain relievers like ibuprofen or acetaminophen?

Regulatory labeling strictly prohibits using this medication alongside other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to avoid increased risks of serious gastrointestinal events. While acetaminophen is not explicitly listed as a contraindication, official guidance emphasizes not exceeding the total recommended daily dosage for any co-administered pain reliever.

Q: Can people with high blood pressure use Antiflu?

Official documents list high blood pressure under the category of conditions that require conditional use and restriction. This means that individuals with this condition are advised to consult with a health professional before use.

Q: Can older adults use Antiflu without special concerns?

According to official labeling, individuals aged 60 and older are documented to have increased risks for certain issues compared to younger adults. Specifically, this includes heightened sensitivity to the central nervous system effects and a greater risk for NSAID-related gastrointestinal issues.

Q: Are the reported side effects the same for children and adults taking Antiflu?

Official drug information indicates that the risk profile is not uniform across all age groups. Use is restricted for children under 12, and older adults are documented to have increased risks for certain side effects, indicating a non-uniform risk profile across eligible populations.

Q: Can Antiflu be taken by individuals who are allergic to eggs?

The official contraindications focus on known hypersensitivity or allergy to any of the four active components (Ibuprofen, Pseudoephedrine, Chlorphenamine, Caffeine) or to aspirin and other NSAIDs. Other specific food allergies are not listed in the contraindications for this medicine.

Q: Does Antiflu interact with common medications for heartburn or acid reflux?

The medication contains an NSAID component which is associated with a risk of gastrointestinal irritation. To help reduce the potential for stomach discomfort, official administration guidance notes that the preparation may be taken with food or milk.

Q: Can Antiflu be taken with food or on an empty stomach?

According to official administration instructions, the preparation may be taken with food or milk. This context is provided to help mitigate potential gastrointestinal discomfort associated with the medication.

Q: What kind of monitoring is recommended while taking Antiflu?

Official guidance on eligibility places restrictions or conditions on use for individuals with severe pre-existing conditions, such as severe liver or kidney disease. Consultation with a health professional is advised to discuss these conditions before use.

How should Antiflu be stored and disposed of?

The official regulatory guidelines for Antiflu (Ibuprofen, Pseudoephedrine, Chlorphenamine, Caffeine) specify mandatory requirements for storage and disposal.

Storage Requirements

Antiflu must be stored at controlled room temperature, typically maintained below 25 C (77 F) or 30 C (86 F). The product must be kept in its original container, which should be tightly closed to ensure protection from light and moisture. Regulatory documents explicitly state that the medicine must not be frozen and should be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Antiflu must not be disposed of in household trash or via the wastewater system (flushing). Disposal must be handled according to local regulatory requirements, which often require returning the product to a pharmacy or an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antiflu found in:

A-Z Index: